No photo of A.W. van Wijk

A.W. van Wijk

20092014

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Incidence of T790M mutation in (sequential) rebiopsies in EGFR-mutated NSCLC-patients

Kuiper, J. L., Heideman, D. A. M., Thunnissen, E., Paul, M. A., van Wijk, A. W., Postmus, P. E. & Smit, E. F., 2014, In : Lung Cancer. 85, 1, p. 19-24

Research output: Contribution to journalArticleAcademicpeer-review

A Phase II Study of Sorafenib in Patients with Platinum-Pretreated, Advanced (Stage IIIb or IV) Non-Small Cell Lung Cancer with a KRAS Mutation

Dingemans, A. M. C., Mellema, W. W., Groen, H. J. M., van Wijk, A. W., Burgers, S. A., Kunst, P. W., Thunnissen, E., Heideman, D. A. M. & Smit, E. F., 2013, In : Clinical Cancer Research. 19, 3, p. 743-751

Research output: Contribution to journalArticleAcademicpeer-review

Retreatment with erlotinib: Regain of TKI sensitivity following a drug holiday for patients with NSCLC who initially responded to EGFR-TKI treatment

Becker, A., Crombag, L., Heideman, D. A. M., Thunnissen, F. B. J. M., van Wijk, A. W., Postmus, P. E. & Smit, E. F., 2011, In : European Journal of Cancer. 47, 17, p. 2603-2606

Research output: Contribution to journalArticleAcademicpeer-review

Pemetrexed and cisplatin with concurrent radiotherapy for locally advanced non-small cell and limited disease small cell lung cancer: Results from 2 phase I studies

Surmont, V., Smit, E. F., de Jonge, M., Aerts, JG., Nackaerts, K., Vernhout, R., Gras, J., van Wijk, A. W., Phernambucq, E. C. J., van Meerbeeck, JP., Senan, S., Kraaij, C. J., Chouaki, N., Praag, J. & van Klaveren, RJ., 2010, In : Lung Cancer. 69, 3, p. 302-306

Research output: Contribution to journalArticleAcademicpeer-review